Gene · 8506
Papers1,771
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,771
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in the treatment of autoimmune nodopathy: based on treatment strategies of CIDP. | Front Immunol | 2026 | 41890726 | PubTator, text mining | PubMed |
| Microsporidian Encephalitozoon hellem inhibits host mitophagy by inducing ERAD to degrade BNIP3L. | PLoS Pathog | 2026 | 41871091 | PubTator, text mining | PubMed |
| Efficacy and safety of anti-CD20 monoclonal antibody therapy for autoimmune nodopathies: a systematic review and meta-analysis. | Front Neurol | 2026 | 41809187 | PubTator, text mining | PubMed |
| BCR::ABL1 Mutational Profiling in US Patients With Chronic-phase Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors. | Cancer Diagn Progn | 2026 | 41778234 | PubTator, text mining | PubMed |
| The Axon as a Self-Modifying Computational System: Autonomous Inference, Adaptive Propagation, and AI-Enabled Mechanistic Insight. | Int J Mol Sci | 2026 | 41751965 | PubTator, text mining | PubMed |
| CRISPRi Screening Identifies Essential E. coli Virulence Factors for Placental Barrier Breach in a Maternal-Fetal Infection Model. | Int J Mol Sci | 2026 | 41751799 | PubTator, text mining | PubMed |
Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCT. | Curr Oncol | 2026 | 41744891 | PubTator, text mining | PubMed |
| Infants exposed to maternal type 1 diabetes: intrauterine epigenetic modifications and neurological development. | Front Endocrinol (Lausanne) | 2026 | 41743545 | PubTator, text mining | PubMed |
| Familial Occurrence of Anti-NF155 Autoimmune Nodopathy in Father and Son: Expanding the Spectrum of IgG4-Related Nodopathies. | Case Rep Neurol Med | 2026 | 41743127 | PubTator, text mining | PubMed |
| Clinical course and prognosis of chronic autoimmune neuropathies requiring intensive care: a retrospective cohort study. | J Neurol | 2026 | 41739210 | PubTator, text mining | PubMed |
| Secondary Chronic Myeloid Leukemia in the Blast Phase With Mixed Phenotype After Radiation Therapy: A Case Report. | EJHaem | 2026 | 41737783 | PubTator, text mining | PubMed |
| Molecular background of Philadelphia chromosome dependent enhancement of cellular growth and tyrosine kinase inhibitor sensitivity. | Exp Hematol Oncol | 2026 | 41715231 | PubTator, text mining | PubMed |
| Human CNTNAP1 Variants Associated With Severe Neurological Deficits: Additional Cases and Literature Review. | Muscle Nerve | 2026 | 41656591 | PubTator, text mining | PubMed |
| Clinical characteristics and treatment outcomes of pediatric Philadelphia chromosome positive acute lymphoblastic leukemia: a comparative analysis of p190 and p210 subtypes in the TKI era. | Leuk Lymphoma | 2026 | 41655204 | PubTator, text mining | PubMed |
| Clinical Insights Into CASPR1 and CASPR1/Contactin-1 Complex Autoimmune Nodopathies. | Neurology | 2026 | 41650362 | PubTator, text mining | PubMed |
| Prognostic Differences Between P190 and P210 BCR::ABL1 in Patients with Philadelphia-Positive B-cell Acute Lymphoblastic Leukemia. | Indian J Hematol Blood Transfus | 2026 | 41522562 | PubTator, text mining | PubMed |
| Caspr1 silencing promotes axon regeneration in both peripheral and central nervous systems via negative regulation of neurofascin. | Biochem Biophys Res Commun | 2026 | 41519054 | PubTator, text mining | PubMed |
| Quantitative reverse transcription PCR coupled with high-resolution melting for simultaneous detection and quantification of four isoforms of BCR::ABL1. | J Clin Pathol | 2026 | 41506866 | PubTator, text mining | PubMed |
| Comparative Analytical Performance of Autoimmune Nodopathy Diagnostic Assays. | Ann Lab Med | 2026 | 41412761 | PubTator, text mining | PubMed |
| Validation and optimisation of a commercial cell-based assay for detection of nodo-paranodal antibodies. | Pathology | 2026 | 41015758 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8506/papers?page=2